Fredericton, Canada

Steve Griffiths

This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2005-2010.


% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Fish Vaccination by Steve Griffiths

Introduction

Steve Griffiths is an accomplished inventor based in Fredericton, Canada. He has made significant contributions to the field of aquaculture, particularly in the development of vaccines for fish. With a total of 2 patents, his work focuses on protecting salmon from infections that can threaten their health and the aquaculture industry.

Latest Patents

Griffiths' latest patents revolve around a fish vaccine designed to protect salmon against infections. The invention is based on or derived from the nucleic acid or amino acid sequences of antigens from Piscirickettsia salmonis. These sequences may be utilized in the preparation of a vaccine, providing a crucial defense against this harmful pathogen.

Career Highlights

Steve Griffiths has established himself as a key figure in the field of fish vaccination. His innovative approaches have the potential to enhance the health and sustainability of salmon farming. Working at Novartis Ag, he has been able to leverage his expertise to develop solutions that address critical challenges in aquaculture.

Collaborations

Griffiths collaborates with notable colleagues, including Nathalie C Simard and Huub Brouwers. Their combined efforts contribute to advancing research and development in fish health and vaccination.

Conclusion

Steve Griffiths is a pioneering inventor whose work in fish vaccination is making a significant impact on the aquaculture industry. His innovative patents and collaborations are paving the way for healthier fish populations and more sustainable farming practices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…